Subvalvular Pannus overgrowth after mosaic bioprosthesis implantation in the aortic position

Masanori Hirota, Tadashi Isomura, Minoru Yoshida, Chieko Katsumata, Fusahiko Ito, Masazumi Watanabe

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Purpose: Although pannus overgrowth by itself was not the pathology of structural valve deterioration (SVD), it might be related to reoperation for SVD of the bioprostheses. Methods: We retrospectively reviewed patients undergoing reoperation for SVD after implantation of the third-generation Mosaic aortic bioprosthesis and macroscopic appearance of the explanted valves was examined to detect the presence of pannus. Results: There were 10 patients and the age for the initial aortic valve replacement was 72 ± 10 years old. The duration of durability was 9.9 ± 2.0 years. Deteriorated valve presented stenosis (valvular area of 0.96 ± 0.20 cm2; pressure gradient of 60 ± 23 mmHg). Coexisting regurgitant flow was detected in two cases. Macroscopically, subvalvular pannus overgrowth was detected in 8 cases (80%). The proportion of overgrowth from the annulus was almost even and pannus overgrowth created subvalvular membrane, which restricted the area especially for each commissure. In contrast, opening and mobility of each leaflet was not severely limited and pannus overgrowth would restrict the area, especially for each commissure. In other two cases with regurgitation, tear of the leaflet on the stent strut was detected and mild calcification of each leaflet restricted opening. Conclusion: In patients with the Mosaic aortic bioprosthesis, pannus overgrowth was the major cause for reoperation.

Original languageEnglish
Pages (from-to)108-111
Number of pages4
JournalAnnals of Thoracic and Cardiovascular Surgery
Volume22
Issue number2
DOIs
Publication statusPublished - Apr 20 2016
Externally publishedYes

Fingerprint

Bioprosthesis
Reoperation
Tears
Aortic Valve
Stents
Pathologic Constriction
Pathology
Pressure
Membranes

Keywords

  • Bioprosthesis
  • Mosaic valve
  • Pannus
  • Reoperation

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine
  • Gastroenterology

Cite this

Subvalvular Pannus overgrowth after mosaic bioprosthesis implantation in the aortic position. / Hirota, Masanori; Isomura, Tadashi; Yoshida, Minoru; Katsumata, Chieko; Ito, Fusahiko; Watanabe, Masazumi.

In: Annals of Thoracic and Cardiovascular Surgery, Vol. 22, No. 2, 20.04.2016, p. 108-111.

Research output: Contribution to journalArticle

Hirota, Masanori ; Isomura, Tadashi ; Yoshida, Minoru ; Katsumata, Chieko ; Ito, Fusahiko ; Watanabe, Masazumi. / Subvalvular Pannus overgrowth after mosaic bioprosthesis implantation in the aortic position. In: Annals of Thoracic and Cardiovascular Surgery. 2016 ; Vol. 22, No. 2. pp. 108-111.
@article{86f33ef56f50406c8e9a550098a716b5,
title = "Subvalvular Pannus overgrowth after mosaic bioprosthesis implantation in the aortic position",
abstract = "Purpose: Although pannus overgrowth by itself was not the pathology of structural valve deterioration (SVD), it might be related to reoperation for SVD of the bioprostheses. Methods: We retrospectively reviewed patients undergoing reoperation for SVD after implantation of the third-generation Mosaic aortic bioprosthesis and macroscopic appearance of the explanted valves was examined to detect the presence of pannus. Results: There were 10 patients and the age for the initial aortic valve replacement was 72 ± 10 years old. The duration of durability was 9.9 ± 2.0 years. Deteriorated valve presented stenosis (valvular area of 0.96 ± 0.20 cm2; pressure gradient of 60 ± 23 mmHg). Coexisting regurgitant flow was detected in two cases. Macroscopically, subvalvular pannus overgrowth was detected in 8 cases (80{\%}). The proportion of overgrowth from the annulus was almost even and pannus overgrowth created subvalvular membrane, which restricted the area especially for each commissure. In contrast, opening and mobility of each leaflet was not severely limited and pannus overgrowth would restrict the area, especially for each commissure. In other two cases with regurgitation, tear of the leaflet on the stent strut was detected and mild calcification of each leaflet restricted opening. Conclusion: In patients with the Mosaic aortic bioprosthesis, pannus overgrowth was the major cause for reoperation.",
keywords = "Bioprosthesis, Mosaic valve, Pannus, Reoperation",
author = "Masanori Hirota and Tadashi Isomura and Minoru Yoshida and Chieko Katsumata and Fusahiko Ito and Masazumi Watanabe",
year = "2016",
month = "4",
day = "20",
doi = "10.5761/atcs.oa.15-00293",
language = "English",
volume = "22",
pages = "108--111",
journal = "Annals of Thoracic and Cardiovascular Surgery",
issn = "1341-1098",
publisher = "Japanese Association for Coronary Artery Surgery",
number = "2",

}

TY - JOUR

T1 - Subvalvular Pannus overgrowth after mosaic bioprosthesis implantation in the aortic position

AU - Hirota, Masanori

AU - Isomura, Tadashi

AU - Yoshida, Minoru

AU - Katsumata, Chieko

AU - Ito, Fusahiko

AU - Watanabe, Masazumi

PY - 2016/4/20

Y1 - 2016/4/20

N2 - Purpose: Although pannus overgrowth by itself was not the pathology of structural valve deterioration (SVD), it might be related to reoperation for SVD of the bioprostheses. Methods: We retrospectively reviewed patients undergoing reoperation for SVD after implantation of the third-generation Mosaic aortic bioprosthesis and macroscopic appearance of the explanted valves was examined to detect the presence of pannus. Results: There were 10 patients and the age for the initial aortic valve replacement was 72 ± 10 years old. The duration of durability was 9.9 ± 2.0 years. Deteriorated valve presented stenosis (valvular area of 0.96 ± 0.20 cm2; pressure gradient of 60 ± 23 mmHg). Coexisting regurgitant flow was detected in two cases. Macroscopically, subvalvular pannus overgrowth was detected in 8 cases (80%). The proportion of overgrowth from the annulus was almost even and pannus overgrowth created subvalvular membrane, which restricted the area especially for each commissure. In contrast, opening and mobility of each leaflet was not severely limited and pannus overgrowth would restrict the area, especially for each commissure. In other two cases with regurgitation, tear of the leaflet on the stent strut was detected and mild calcification of each leaflet restricted opening. Conclusion: In patients with the Mosaic aortic bioprosthesis, pannus overgrowth was the major cause for reoperation.

AB - Purpose: Although pannus overgrowth by itself was not the pathology of structural valve deterioration (SVD), it might be related to reoperation for SVD of the bioprostheses. Methods: We retrospectively reviewed patients undergoing reoperation for SVD after implantation of the third-generation Mosaic aortic bioprosthesis and macroscopic appearance of the explanted valves was examined to detect the presence of pannus. Results: There were 10 patients and the age for the initial aortic valve replacement was 72 ± 10 years old. The duration of durability was 9.9 ± 2.0 years. Deteriorated valve presented stenosis (valvular area of 0.96 ± 0.20 cm2; pressure gradient of 60 ± 23 mmHg). Coexisting regurgitant flow was detected in two cases. Macroscopically, subvalvular pannus overgrowth was detected in 8 cases (80%). The proportion of overgrowth from the annulus was almost even and pannus overgrowth created subvalvular membrane, which restricted the area especially for each commissure. In contrast, opening and mobility of each leaflet was not severely limited and pannus overgrowth would restrict the area, especially for each commissure. In other two cases with regurgitation, tear of the leaflet on the stent strut was detected and mild calcification of each leaflet restricted opening. Conclusion: In patients with the Mosaic aortic bioprosthesis, pannus overgrowth was the major cause for reoperation.

KW - Bioprosthesis

KW - Mosaic valve

KW - Pannus

KW - Reoperation

UR - http://www.scopus.com/inward/record.url?scp=84964267042&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964267042&partnerID=8YFLogxK

U2 - 10.5761/atcs.oa.15-00293

DO - 10.5761/atcs.oa.15-00293

M3 - Article

C2 - 26633541

AN - SCOPUS:84964267042

VL - 22

SP - 108

EP - 111

JO - Annals of Thoracic and Cardiovascular Surgery

JF - Annals of Thoracic and Cardiovascular Surgery

SN - 1341-1098

IS - 2

ER -